Logo
Apparel & Fashion

Description

AMCLOX-d Tablets represent a sophisticated antibacterial formulation combining Amoxycillin 250mg and Dicloxacillin 250mg in precise therapeutic proportions. This powerful dual-antibiotic approach creates synergistic action against a wide spectrum of bacterial pathogens, ensuring comprehensive infection control. Manufactured under strict pharmaceutical standards, each tablet maintains consistent potency, purity, and safety profiles. The product's reliable performance makes it suitable for diverse treatment protocols where effective bacterial eradication is crucial. Healthcare professionals trust this medication for its predictable results and patient safety record across various clinical applications.

This antibacterial medication finds extensive application across multiple healthcare sectors including hospital medicine, primary care clinics, and veterinary practices. In human healthcare, it is routinely prescribed for respiratory tract infections, skin and soft tissue infections, and ...
AMCLOX-d Tablets represent a sophisticated antibacterial formulation combining Amoxycillin 250mg and Dicloxacillin 250mg in precise therapeutic proportions. This powerful dual-antibiotic approach creates synergistic action against a wide spectrum of bacterial pathogens, ensuring comprehensive infection control. Manufactured under strict pharmaceutical standards, each tablet maintains consistent potency, purity, and safety profiles. The product's reliable performance makes it suitable for diverse treatment protocols where effective bacterial eradication is crucial. Healthcare professionals trust this medication for its predictable results and patient safety record across various clinical applications.

This antibacterial medication finds extensive application across multiple healthcare sectors including hospital medicine, primary care clinics, and veterinary practices. In human healthcare, it is routinely prescribed for respiratory tract infections, skin and soft tissue infections, and postoperative infection prevention. Veterinary practitioners utilize these tablets for treating bacterial conditions in companion animals and livestock. Pharmaceutical distributors supply AMCLOX-d tablets to retail pharmacies, long-term care facilities, and community health centers, ensuring broad availability for both institutional and individual patient needs across different healthcare delivery systems.

The business value of AMCLOX-d tablets lies in their proven reliability, consistent therapeutic outcomes, and comprehensive antibacterial coverage. Healthcare providers benefit from reduced treatment failures and minimized antibiotic resistance development due to the synergistic dual-action formula. The product's manufacturing consistency ensures predictable performance batch after batch, building trust among medical professionals and patients alike. This reliability translates to improved patient outcomes, reduced hospitalization durations, and enhanced infection control protocols. The tablets' suitability for both human and veterinary applications provides distributors with expanded market opportunities and supply chain flexibility.

Key Features:
- Precise combination of Amoxycillin 250mg and Dicloxacillin 250mg
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Manufactured under strict pharmaceutical quality standards
- Suitable for human medical and veterinary applications
- Consistent potency and reliable therapeutic performance

Benefits:
- Effective treatment for various bacterial infections
- Reduced risk of antibiotic resistance development
- Trusted by healthcare professionals worldwide
- Versatile applications across multiple treatment settings
- Consistent quality ensuring predictable clinical outcomes

Specifications

Additional Information
Country of OriginIndia

Application

AMCLOX-d tablets provide comprehensive antibacterial treatment for various infections in clinical environments. The dual-action formula of Amoxycillin and Dicloxacillin delivers broad-spectrum coverage against gram-positive and gram-negative bacteria, making it effective for respiratory infections, skin conditions, and soft tissue infections. This reliable medication helps healthcare providers maintain high treatment standards while reducing antibiotic resistance risks across diverse medical settings. These tablets serve multiple healthcare sectors including hospital inpatient care, outpatient clinics, and veterinary medicine. Medical distributors supply this product to pharmacies, nursing homes, and community health programs for institutional and retail use. The consistent quality and proven efficacy make AMCLOX-d tablets a preferred choice for infection management in human healthcare, animal health, and pharmaceutical distribution networks worldwide. - Treatment of bacterial pneumonia and bronchitis in hospital settings - Management of skin and soft tissue infections including cellulitis - Postoperative surgical site infection prevention and control - Veterinary applications for bacterial infections in livestock - Retail pharmacy distribution for community health programs

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Beatle Health Care, Gujarat
TruBasic
IndiaGujarat, India
Manufacturer•Trading Company•Distributor / Wholesaler
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

AMCLOX d Tablets Amoxycillin Dicloxacillin Antibacterial 500mg

AMCLOX-d Tablets combine Amoxycillin 250mg and Dicloxacillin 250mg for potent antibacterial treatment. This reliable pharmaceutical solution effectively addresses bacterial infections in hospitals, clinics, and veterinary practices with consistent quality and broad-spectrum coverage.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Beatle Health Care
TruBasic
IndiaGujarat, India
Manufacturer

More Products From Supplier